TABLE 6.
% Contraction Inhibition | ||||
---|---|---|---|---|
Treatment | 0.00003 M CaCl2 | 0.0003 M CaCl2 | 0.003 M CaCl2 | 0.03 M CaCl2 |
Negative control | 14.65 ± 1.65 | 24.61 ± 2.01 | 84.49 ± 2.01 | 100 ± 0.00 |
TFG (mg/ml) 1.0 | 13.81 ± 1.84 | 18.45 ± 2.86 | 56.30± 9.28 | 55.62 ± 6.20* |
2.5 | 14.18 ± 1.75 | 13.89 ± 2.22* | 48.30 ± 9.36* | 59.48 ± 9.36** |
3.5 | 13.69 ± 1.13 | 12.02 ± 0.9* | 60.18 ± 11.02 | 65.51 ± 8.78** |
0.025 mM verapamil | 12.56 ± 0.88 | 15.20 ± 2.12* | 15.88 ± 2.39** | 17.11 ± 2.45** |
Compared with negative control group: *p < 0.05, **p < 0.01. ANOVA followed by Turkey’s multiple comparison test.